As of 2025-07-11, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is -19.67 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.05 CAD, the upside of Aptose Biosciences Inc is -1,059.75%.
Based on its market price of 2.05 CAD and our intrinsic valuation, Aptose Biosciences Inc (APS.TO) is overvalued by 1,059.75%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.67 - -19.67 | -19.67 | -1,059.75% |
| DDM - Stable | (253.16) - (894.20) | (573.68) | -28084.5% |
| DDM - Multi | (217.84) - (659.04) | (334.48) | -16415.9% |
| Market Cap (mil) | 2.55 |
| Beta | -0.49 |
| Outstanding shares (mil) | 1.25 |
| Enterprise Value (mil) | -7.44 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.73% |
| Cost of Debt | 5.00% |
| WACC | 8.71% |